Literature DB >> 1701511

Clinicopathological characteristics of hepatocellular carcinoma bearing Mallory bodies: an autopsy study.

M Hoso1, Y Nakanuma.   

Abstract

Mallory bodies are known to occur in hepatocellular carcinoma. The simple question whether or not there are any clinicopathological features characterizing Mallory body-positive hepatocellular carcinoma remains unresolved to date. The present study of 200 consecutive autopsy cases of hepatocellular carcinoma showed several important differences between 49 cases bearing Mallory bodies and 151 cases bearing no Mallory bodies in carcinoma cells. The patients in the former group were older, showed a higher association rate of liver cirrhosis, and their liver weight was lighter. As to the gross pathology of hepatocellular carcinoma, the nodular type was relatively frequent in Mallory body-positive hepatocellular carcinoma, while the massive and diffuse types were relatively frequent in Mallory body-negative cases. The frequency of extrahepatic metastases in the Mallory body-positive group was lower than that in the Mallory body-negative cases. The reasons for these differences remain speculative.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701511     DOI: 10.1111/j.1600-0676.1990.tb00468.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.

Authors:  C Stumptner; H Heid; A Fuchsbichler; H Hauser; H J Mischinger; K Zatloukal; H Denk
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Hepatoid carcinoma of the skin: spontaneous rat skin hepatoid carcinoma with eosinophilic globules and crystals immunoreactive to alpha-1-antitrypsin.

Authors:  Mihoko Sutoh; Mitsuru Chiba; Kosuke Kasai; Tomisato Miura; Hiroyuki Nozaka; Kiyotada Washiya; Etsuko Okusawa; Naoto Oyama; Chikako Tsutaya; Megumi Tsushima; Yuriko Terayama; Tomihisa Funyu; Tatsusuke Sato
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

3.  Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant.

Authors:  J E Coe; K G Ishak; J M Ward; M J Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.